Related Experiment Video
Updated: Jul 23, 2025

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Strategies to Cultivate Diversity and Achieve Equity in Cardiovascular Clinical Trials
Debra D Dixon1,2, Consuelo H Wilkins3,4
1Vanderbilt Translational and Clinical Cardiovascular Research Center (D.D.D.), Vanderbilt University Medical Center, Nashville, TN.
No abstract available in PubMed .
More Related Videos
14:43A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
09:55Bridging the Technology Divide in the COVID-19 Era: Using Virtual Outreach to Expose Middle and High School Students to Imaging Technology
Published on: September 28, 2022
Related Concept Videos
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Coronary Artery Disease IV: Preventive Measures
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Coronary Artery Disease V: Interprofessional Care